Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Not applicable Interventional

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation

ClinicalTrials.gov ID: NCT07575269

Public ClinicalTrials.gov record NCT07575269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 9:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation - A Global Prospective Single Arm Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of this clinical trial is to learn if the FARAFLEX™ Mapping and pulsed field ablation (PFA) System can safely and effectively treat symptomatic, drug-refractory Paroxysmal atrial fibrillation (PAF) and Persistent atrial fibrillation (PersAF). The main question it aims to answer is: Is the FARAFLEX Mapping and PFA System a safe and effective treatment for patients? Participants will undergo an ablation procedure using the FARAFLEX Mapping and PFA System.

Study identification

NCT ID
NCT07575269
Recruitment status
Recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
571 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2026
Primary completion
Jul 19, 2028
Completion
Dec 31, 2029
Last update posted
Aug 27, 2026

2026 – 2030

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Arrhythmia Research Group Jonesboro Arkansas 72401 Recruiting
Emory Saint Joseph's Hospital Atlanta Georgia 30342 Recruiting
Mount Sinai Medical Center-Hospital New York New York 10029 Recruiting
OhioHealth Research and Innovation Institute - Riverside Methodist Hospital Columbus Ohio 43214 Recruiting
Pinnacle Health at Harrisburg Hospital - UPMC Pinnacle Mechanicsburg Pennsylvania 17050 Recruiting
Texas Cardiac Arrhythmia Research Austin Texas 78705 Recruiting
Christus Trinity Mother Frances Health System-Hospital Tyler Texas 75701 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07575269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2026 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07575269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →